Bernt, Kathrin M. http://orcid.org/0000-0002-0691-356X
Article History
First Online: 21 March 2024
Competing interests
: K.M.B. declares that they have consulted for Agios and Novartis and have received research funding from Syndax Pharmaceuticals. These contributions are unrelated to the subject material discussed in this article.